awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38788657-07BCDA83-86C1-4ED6-A390-5892E5C0E5A9
Q38788657-07BCDA83-86C1-4ED6-A390-5892E5C0E5A9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38788657-07BCDA83-86C1-4ED6-A390-5892E5C0E5A9
A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia.
P2860
Q38788657-07BCDA83-86C1-4ED6-A390-5892E5C0E5A9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38788657-07BCDA83-86C1-4ED6-A390-5892E5C0E5A9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a8dc2de0e31cb4dbdd34f45116305dd957cbc2a
P2860
A phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis.